CS277650B6 - Combination preparation with anti-thrombotic effect - Google Patents

Combination preparation with anti-thrombotic effect Download PDF

Info

Publication number
CS277650B6
CS277650B6 CS904726A CS472690A CS277650B6 CS 277650 B6 CS277650 B6 CS 277650B6 CS 904726 A CS904726 A CS 904726A CS 472690 A CS472690 A CS 472690A CS 277650 B6 CS277650 B6 CS 277650B6
Authority
CS
Czechoslovakia
Prior art keywords
acetylsalicylic acid
kas
platelet
carbacycline
significant
Prior art date
Application number
CS904726A
Other languages
Czech (cs)
English (en)
Other versions
CS472690A3 (en
Inventor
Werner Witt
Berthold Baldus
Bernd Dr Muller
Claus-Steffen Dr Sturzebecher
Werner Dr Skuballa
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CS472690A3 publication Critical patent/CS472690A3/cs
Publication of CS277650B6 publication Critical patent/CS277650B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CS904726A 1989-09-29 1990-09-28 Combination preparation with anti-thrombotic effect CS277650B6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3933027A DE3933027A1 (de) 1989-09-29 1989-09-29 Kombinationspraeparat mit antithrombotischer wirkung

Publications (2)

Publication Number Publication Date
CS472690A3 CS472690A3 (en) 1992-08-12
CS277650B6 true CS277650B6 (en) 1993-03-17

Family

ID=6390758

Family Applications (1)

Application Number Title Priority Date Filing Date
CS904726A CS277650B6 (en) 1989-09-29 1990-09-28 Combination preparation with anti-thrombotic effect

Country Status (19)

Country Link
US (1) US5093325A (fr)
EP (1) EP0420368B1 (fr)
JP (1) JP3040463B2 (fr)
AT (1) ATE92325T1 (fr)
CA (1) CA2069296C (fr)
CS (1) CS277650B6 (fr)
DD (1) DD299153A5 (fr)
DE (2) DE3933027A1 (fr)
DK (1) DK0420368T3 (fr)
ES (1) ES2058771T3 (fr)
HU (1) HUT60140A (fr)
IE (1) IE903503A1 (fr)
IL (1) IL95849A (fr)
NO (1) NO921223L (fr)
NZ (1) NZ235521A (fr)
PT (1) PT95456B (fr)
RU (1) RU2097039C1 (fr)
WO (1) WO1991004740A1 (fr)
ZA (1) ZA907808B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040180865A1 (en) * 1993-06-04 2004-09-16 Jeffry W. Kreamer Aspirin and vitamin and/or trace element compositions for the amelioration and treatment of vascular disease
US5830837A (en) * 1994-11-22 1998-11-03 Novo Nordisk A/S Amylase variants
US5709541A (en) * 1995-06-26 1998-01-20 Selas Corporation Of America Method and apparatus for reducing NOx emissions in a gas burner
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
EP1596858A1 (fr) * 2003-02-14 2005-11-23 Medical Research Council Antagonistes du récepteur ip utilises dans le traitement des pathologies de l'utérus
WO2005116623A2 (fr) * 2004-05-17 2005-12-08 Medtronic, Inc. Systeme de determination de l'heparine selon les points d'intervention
DK2026651T3 (da) * 2006-03-08 2013-07-08 Cortria Corp Kombinationsterapi med ikke-selektive COX-inhibitorer til forebyggelse af COX-relaterede maveskader
US20130040898A1 (en) * 2010-04-29 2013-02-14 Pär Johansson Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof
WO2014164886A1 (fr) * 2013-03-13 2014-10-09 Allergan, Inc. Composés agonistes des récepteurs des prostanoïdes et leur utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524051A1 (de) * 1985-07-05 1987-01-15 Hoechst Ag Kombinationspraeparate aus hemmstoffen der thrombozytenaggregation und deren verwendung

Also Published As

Publication number Publication date
CS472690A3 (en) 1992-08-12
WO1991004740A1 (fr) 1991-04-18
ATE92325T1 (de) 1993-08-15
IL95849A0 (en) 1991-06-30
CA2069296C (fr) 2002-04-23
NO921223D0 (no) 1992-03-27
US5093325A (en) 1992-03-03
IL95849A (en) 1995-03-30
NO921223L (no) 1992-03-27
HUT60140A (en) 1992-08-28
DD299153A5 (de) 1992-04-02
EP0420368B1 (fr) 1993-08-04
JPH05500805A (ja) 1993-02-18
ES2058771T3 (es) 1994-11-01
PT95456A (pt) 1991-08-14
RU2097039C1 (ru) 1997-11-27
IE903503A1 (en) 1991-04-10
AU640692B2 (en) 1993-09-02
CA2069296A1 (fr) 1991-03-30
HU9201045D0 (en) 1992-06-29
DE3933027A1 (de) 1991-04-11
DE59002185D1 (de) 1993-09-09
DK0420368T3 (da) 1993-11-15
EP0420368A1 (fr) 1991-04-03
JP3040463B2 (ja) 2000-05-15
ZA907808B (en) 1992-01-29
AU6419090A (en) 1991-04-28
NZ235521A (en) 1993-03-26
PT95456B (pt) 1997-07-31

Similar Documents

Publication Publication Date Title
US4451454A (en) Prophylaxis and treatment of thromboembolic disorders in man and in warm-blooded animals with bicarbonate salts of alkali metals
US6855734B2 (en) Glycine betaine and its use
US5576304A (en) Antithrombotic composition
AU754405B2 (en) A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
Küster et al. Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man
CZ446099A3 (cs) Použití inhibitoru faktoru Xa, samotného nebo v kombinaci s činidlem proti shlukování krevních destiček a farmaceutické prostředky, které obsahují tyto složky
CS277650B6 (en) Combination preparation with anti-thrombotic effect
NZ518904A (en) A pharmaceutical composition comprising a P2T receptor antagonist, or a pharmaceutically acceptable salt thereof, and an anti-thrombotic agent, and the use of the combination in the treatment and prevention of thrombosis
CN103908460B (zh) 三七皂苷Fc的医药用途
Neubauer et al. Inhibitory effect of warfarin on the metastasis of the PAIII prostatic adenocarcinoma in the rat
Shirakura et al. Antithrombotic effects of KW-3635, a thromboxane A2-receptor antagonist, in guinea pigs
Ito et al. Role of activated platelets in endotoxin-induced DIC in rats
BOLTON Disseminated intravascular coagulation
US5932603A (en) Thrombolytic agents
Vlădăreanu et al. Factor XI and coagulation. Factor XI inhibitors-antithrombotic perspectives
US4400397A (en) Antithrombotic treatment with quaternary ammonium sulfites and bisulfites
US3721738A (en) Treatment and prophylaxis of thrombovascular diseases with 2-imidazolone derivatives
Keraly et al. Specific desensitization of washed rabbit platelets by PAF-acether and derivatives
Nossel et al. B. Anticoagulants
HUT77739A (hu) Orálisan adagolható, dihidro-imidazol-származékot tartalmazó trombolitikus szer
Levi et al. Hemostasis and
Sandberg et al. The Appearance Of PF1 And PF3 In Activated Human Platelets
Bergqvist et al. Platelet-Influencing Agents
Vargaftig et al. Interference Of Sulphynpyrazone With The Platelet And Bronchial Effects Of “Platelet-Activating Factor”
MXPA01010512A (es) Formulacion farmaceutica que comprende inhibidor de trombina de bajo peso molecular y su profarmaco

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20030928